Background Approved systemic treatments for malignant pleural mesothelioma (MPM) have
been limited to chemotherapy regimens that have moderate survival benefit with poor …

Malignant pleural mesothelioma (MPM) is characterised by late-stage diagnosis and poor
prognosis. Currently, no screening tool is advocated and diagnosis is based on invasive …

Mesothelioma is a type of late‐onset cancer that develops in cells covering the outer surface
of organs. Although it can affect the peritoneum, heart, or testicles, it mainly targets the lining …

Importance Some recently proposed frontline therapies for malignant pleural mesothelioma
(MPM) are very costly, yet their impact on quality of life and overall survival of these patients …

Current Opinion in Oncology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Background The exact role and type of surgery for malignant pleural mesothelioma (MPM)
remains controversial. This study aimed at analyzing a 20-year single center perioperative …

Cytology effusions are often the only material available for diagnosing malignant pleural
mesothelioma (MPM). However, the cytomorphological features alone are not always …

Malignant pleural mesothelioma is an aggressive, incurable cancer that is usually caused by
asbestos exposure several decades before symptoms arise. Despite widespread prohibition …

Most patients with pleural mesothelioma (PM) present with symptomatic pleural effusion. In
some patients, PM is only detectable on the pleural surfaces, providing a strong rationale for …

Malignant pleural mesothelioma (MPM), an aggressive cancer associated with exposure to
fibrous minerals, can only be diagnosed in the advanced stage because its early symptoms …